Skip to main content
Quest Diagnostics Home

Innovative tests

BRCAvantage™

BRCAvantage™

Genetic testing for BRCA1 and BRCA2 is available from Quest Diagnostics.

Breast and ovarian cancers are common cancers that affect women. But only some of them are hereditary.  Hereditary cancer can happen when a parent passes on a mutation (change) in a BRCA1 or BRCA2 gene to a son or daughter. Changes in these 2 genes cause about 3% to 5% of all cancers in the breast and up to 15% of all cancers in the ovary. Changes in the 2 genes also increase the risk for breast and/or prostate cancer in men.

Learn More
Female doctor and patient in personal protective equipment at medical exam.

Cardio IQ®

Cardio IQ®

A comprehensive approach for helping you assess cardiovascular risk, guide treatment, and monitor response.

The Cardio IQ® Report provides an in-depth analysis of your patient's cardiac health, based on a number of different factors, from basic lipids to lipoprotein subfractionation.

Learn More

Exames inovadores

Innovative tests

Ver Em Portuguese
Innovative tests

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy   •   Terms   •   Cookie notice   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   DO NOT SELL MY PERSONAL INFORMATION

Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000-2021 Quest Diagnostics Incorporated. All rights reserved.
Image content features models and is intended for illustrative purposes only.